Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 100 | $8.86 | $886.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 22, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 12 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,957 Underlying: Common Stock · 100 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F6 · balance_after: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020. Read SEC document |
| July 22, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 100 | $32.00 | $3,200.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 7 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 22, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 100 | $8.86 | $886.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:16 UTC |
Hanna John Walter JRChief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 653 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · derivative · entry 6 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 653 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:16 UTC |
Hanna John Walter JRChief Commercial Officer
|
SaleCommon Stock | 653 | $32.36 | $21,131.08 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:16 UTC |
Hanna John Walter JRChief Commercial Officer
|
Exercise / conversionCommon Stock | 653 | $2.40 | $1,567.20 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,447 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 11 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,619 Underlying: Common Stock · 3,447 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 3,447 | $32.09 | $110,613.54 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.25. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 3,447 | $8.86 | $30,540.42 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 21, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,447 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 11 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,057 Underlying: Common Stock · 3,447 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F6 · balance_after: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020. Read SEC document |
| July 21, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 3,447 | $32.09 | $110,613.54 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.25. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 21, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 3,447 | $8.86 | $30,540.42 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:16 UTC |
Hanna John Walter JRChief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,294 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · derivative · entry 5 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653 Underlying: Common Stock · 11,294 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:16 UTC |
Hanna John Walter JRChief Commercial Officer
|
SaleCommon Stock | 11,294 | $32.05 | $361,993.03 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.32. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:16 UTC |
Hanna John Walter JRChief Commercial Officer
|
Exercise / conversionCommon Stock | 11,294 | $2.40 | $27,105.60 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,496 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 10 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,066 Underlying: Common Stock · 18,496 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,853 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · derivative · entry 9 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,853 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F5 · balance_after: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 1,853 were exercised on 07/20/2020 and none remain. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 20,349 | $32.04 | $651,910.74 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.34. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 18,496 | $8.86 | $163,874.56 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:09 UTC |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 1,853 | $4.00 | $7,412.00 |
DisclosureSEC source: 0001437749-20-015554 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,496 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 10 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,504 Underlying: Common Stock · 18,496 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F6 · balance_after: The total reported in Column 9 has been adjusted to correct an understatement of total holdings by 98,438 shares as reflected in Form 4 filed on July 22, 2020. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,853 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · derivative · entry 9 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,853 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: The option is fully vested. F5 · balance_after: On February 5, 2013, the Reporting Person was issued 3 stock options which have different vesting dates, all of which are vested. These options include: (1) 112,500, of which 25,000 options remain, (2) 12,500, of which none remain and (3) 24,112, of which 1,853 were exercised on 07/20/2020 and none remain. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
SaleCommon Stock | 20,349 | $32.04 | $651,910.74 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,207 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.34. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 18,496 | $8.86 | $163,874.56 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 20, 2020 Filed Jul 27, 2020 21:00 UTC Amendment |
Anderson Bonnie HDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 1,853 | $4.00 | $7,412.00 |
DisclosureSEC source: 0001437749-20-015787 · rdgdoc.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:15 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 3,700 | $30.65 | $113,413.14 |
DisclosureSEC source: 0001437749-20-015296 · rdgdoc.xml · nonDerivative · entry 4 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by jVen Capital, LLC Disclosed balance after: 109,653 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2019. F6 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.49 to $30.91. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F3 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 21:15 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 6,300 | $29.81 | $187,779.06 |
DisclosureSEC source: 0001437749-20-015296 · rdgdoc.xml · nonDerivative · entry 3 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by jVen Capital, LLC Disclosed balance after: 113,353 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2019. F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $29.45 to $30.45. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F3 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:15 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 7,600 | $28.69 | $218,071.36 |
DisclosureSEC source: 0001437749-20-015296 · rdgdoc.xml · nonDerivative · entry 2 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by jVen Capital, LLC Disclosed balance after: 119,653 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2019. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.52 to $29.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F3 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 21:15 UTC |
JONES EVAN/ FADirector
|
SaleCommon Stock | 12,400 | $28.13 | $348,776.04 |
DisclosureSEC source: 0001437749-20-015296 · rdgdoc.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by jVen Capital, LLC Disclosed balance after: 127,253 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $27.51 to $28.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. F3 · ownership.nature: The Reporting Person is the sole managing member of jVen Capital, LLC. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:26 UTC |
EPSTEIN ROBERT SDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.28 | $0.00 |
DisclosureSEC source: 0001437749-20-015124 · rdgdoc.xml · derivative · entry 5 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 10, 2020. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:26 UTC |
EPSTEIN ROBERT SDirector
|
SaleCommon Stock | 1,854 | $30.51 | $56,566.10 |
DisclosureSEC source: 0001437749-20-015124 · rdgdoc.xml · nonDerivative · entry 4 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 10, 2020. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.44 to $30.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:26 UTC |
EPSTEIN ROBERT SDirector
|
SaleCommon Stock | 5,583 | $29.92 | $167,023.82 |
DisclosureSEC source: 0001437749-20-015124 · rdgdoc.xml · nonDerivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,854 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 10, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $29.42 to $30.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:26 UTC |
EPSTEIN ROBERT SDirector
|
SaleCommon Stock | 2,563 | $28.74 | $73,661.90 |
DisclosureSEC source: 0001437749-20-015124 · rdgdoc.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,437 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 10, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.38 to $29.35. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:26 UTC |
EPSTEIN ROBERT SDirector
|
Exercise / conversionCommon Stock | 10,000 | $5.28 | $52,800.00 |
DisclosureSEC source: 0001437749-20-015124 · rdgdoc.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 10, 2020. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,469 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · derivative · entry 9 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,375 Underlying: Common Stock · 1,469 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F7 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,771 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · derivative · entry 8 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,167 Underlying: Common Stock · 1,771 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,498 | $0.00 Strike: $14.34 | $0.00 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · derivative · entry 7 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 Underlying: Common Stock · 13,498 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 200 | $30.46 | $6,091.00 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · nonDerivative · entry 6 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,487 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.45 to $30.46. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 15,814 | $29.69 | $469,520.82 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · nonDerivative · entry 5 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,687 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $29.41 to $30.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
SaleCommon Stock | 724 | $28.82 | $20,865.68 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · nonDerivative · entry 4 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,501 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.40 to $29.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 1,469 | $5.98 | $8,784.62 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · nonDerivative · entry 3 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 1,771 | $9.05 | $16,027.55 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · nonDerivative · entry 2 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 00:29 UTC |
Kennedy Giulia CChief Scientific & Med Officer
|
Exercise / conversionCommon Stock | 13,498 | $14.34 | $193,561.32 |
DisclosureSEC source: 0001437749-20-015126 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Giulia C · CIK 0001769333 · Chief Scientific & Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,416 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 10 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,584 Underlying: Common Stock · 15,416 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,167 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 9 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,223 Underlying: Common Stock · 22,167 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F5 · derivative.exercise_date: The option began to vest on December 6, 2017 and vests at a rate of 1/36th per total number of shares subject to the award each month, subject to the continuing employment of the reporting person on the vesting date. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,075 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 8 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,017 Underlying: Common Stock · 10,075 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
SaleCommon Stock | 80,677 | $28.21 | $2,276,172.47 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 6 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,632 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionCommon Stock | 15,416 | $9.05 | $139,514.80 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 5 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC |
Kennedy KeithCOO / CFO
|
Exercise / conversionCommon Stock | 22,167 | $7.47 | $165,587.49 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 4 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.